Literature DB >> 15011810

Does patient cost sharing matter? Its impact on recommended versus controversial cancer screening services.

Su-Ying Liang1, Kathryn A Phillips, Sherilyn Tye, Jennifer S Haas, Julie Sakowski.   

Abstract

OBJECTIVES: To examine whether there are differential impacts of patient cost sharing and health plan organizational characteristics on the use of a recommended cancer screening service (mammography) versus a controversial cancer screening service (prostate cancer screening [PCS]). STUDY
DESIGN: Observational cohort using the 1996 Medical Expenditure Panel Survey. PATIENTS AND METHODS: A nationally representative sample of privately insured individuals was examined. Outcome measures were the receipt of mammography and PCS. Logistic regression was used to assess the impact of patient cost sharing and health plan organizational characteristics on the receipt of mammography and PCS, controlling for other covariates.
RESULTS: Patient cost sharing and gatekeeper requirements were strong predictors of PCS but were statistically insignificant predictors of mammography. Men in health plans with a copayment over dollar 10 (odds ratio [OR] = 0.38, 95% confidence interval [CI] = 0.19-0.78) or with deductibles over dollar 250 (OR = 0.38, 95% CI = 0.23-0.62) were significantly less likely to receive PCS than men in plans with no or lower copayments and deductibles. Men in gatekeeper plans were less likely to receive PCS than those without gatekeepers (OR = 0.48, 95% CI = 0.29-0.81).
CONCLUSIONS: We found the impact of cost sharing on utilization is different between mammography and PCS. Prostate cancer screening utilization appears to respond to financial incentives while mammography utilization does not. The use of copayments, deductibles, and gatekeepers may discourage controversial services but may not have an adverse effect on more recommended services. These findings have implications for the design of insurance benefits and plan organizational structure.

Entities:  

Mesh:

Year:  2004        PMID: 15011810

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  8 in total

1.  Mammography Use Among Medicare Beneficiaries After Elimination of Cost Sharing.

Authors:  Susan A Sabatino; Trevor D Thompson; Gery P Guy; Janet S de Moor; Florence K Tangka
Journal:  Med Care       Date:  2016-04       Impact factor: 2.983

2.  Effect of cost-sharing reductions on preventive service use among Medicare fee-for-service beneficiaries.

Authors:  Suzanne M Goodwin; Gerard F Anderson
Journal:  Medicare Medicaid Res Rev       Date:  2012-02-08

3.  Prevalence of Out-Of-Pocket Payments for Mammography Screening Among Recently Screened Women.

Authors:  Susan A Sabatino; Trevor D Thompson; Jacqueline W Miller; Nancy Breen; Mary C White; Erica Breslau; Meredith L Shoemaker
Journal:  J Womens Health (Larchmt)       Date:  2018-09-28       Impact factor: 2.681

4.  Two-year trends in cancer screening among low socioeconomic status women in an HMO-based high-deductible health plan.

Authors:  J Frank Wharam; Amy Johnson Graves; Fang Zhang; Stephen B Soumerai; Dennis Ross-Degnan; Bruce E Landon
Journal:  J Gen Intern Med       Date:  2012-04-29       Impact factor: 5.128

5.  The Impact of a Tiered Network on Hospital Choice.

Authors:  Matthew B Frank; John Hsu; Mary Beth Landrum; Michael E Chernew
Journal:  Health Serv Res       Date:  2015-03-09       Impact factor: 3.402

6.  Moving beyond the typologies of managed care: the example of health plan predictors of screening mammography.

Authors:  Sherilyn Tye; Kathryn A Phillips; Su-Ying Liang; Jennifer S Haas
Journal:  Health Serv Res       Date:  2004-02       Impact factor: 3.402

7.  Rates and predictors of colorectal cancer screening.

Authors:  Su-Ying Liang; Kathryn A Phillips; Mika Nagamine; Uri Ladabaum; Jennifer S Haas
Journal:  Prev Chronic Dis       Date:  2006-09-15       Impact factor: 2.830

8.  Screening rates and characteristics of health plan members who respond to screening reminders.

Authors:  Jun Zhu; James Davis; Deborah A Taira; Marisa Yamashita
Journal:  Prev Chronic Dis       Date:  2006-03-15       Impact factor: 2.830

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.